Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用
基本信息
- 批准号:10662347
- 负责人:
- 金额:$ 37.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-25 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectBindingBiological AssayCalciumCardiacCardiac MyocytesCellsChromatinCicatrixComputer AnalysisDataDermalDeveloped CountriesDevelopmentFamilyFibroblastsFutureGene ActivationGene Expression ProfilingGenerationsGenesGeneticGenetic TranscriptionGenomicsHeartHeart InjuriesHeart failureHistonesHumanImageIn SituIn VitroInjuryIntercellular JunctionsIon ChannelLeft ventricular structureMapsMembraneMolecularMorbidity - disease rateMusMyocardial InfarctionMyocardial IschemiaMyofibrilsNatural regenerationNeonatalOpticsPatientsPerformancePlayProcessProliferatingRegulationReportingResearchResidual stateRoleRouteSarcomeresStructureSystemTechnologyTestingTherapeuticTimeTissuesTransactivationTransmission Electron Microscopycardiac repairclinical applicationclinical translationcofactorepigenomicsgenetic signaturein vivoinducible gene expressioninsightloss of functionmortalitymouse modelmultiple omicsnoveloverexpressionpenis foreskinprogramsprotein expressionsingle-cell RNA sequencingstem cell differentiationtranscription factortranscriptometranscriptomicstreatment strategytumorigenesisvoltage
项目摘要
SUMMARY
Direct cardiac reprogramming to generated induced cardiomyocytes (iCMs) from fibroblasts has emerged as a
promising therapeutic strategy for the treatment of heart failure, which is still the leading cause of mortality and
morbidity in the developed country. While much is known regarding iCMs generated from mouse cells, the
adaptation of direct cardiac reprogramming to human cells is hurdled with low efficiency and poor quality
because of intrinsic differences between species. We recently reported the single cell transcriptomic analysis
during human cardiac reprogramming and discovered that the insufficient generation of iCMs is associated
with underdeveloped gene programs, such as ion channel and cell junction, suggesting that additional
reprogramming factors regulating function of cardiomyocytes might be required. In this research program, we
hypothesis that a novel reprogramming factor TBX20 plays an essential role to generate cardiomyocyte identity
by establishing gene programs associated with cardiomyocyte function. In support of our hypothesis, our
preliminary data have shown that TBX20 is largely under-expressed in human iCMs. While forced expression
of TBX20 significantly enhanced reprogramming efficiency accompanied with activation of gene programs
associated with cardiomyocyte function. To test the hypothesis, we propose to 1) further determine the impact
of TBX20 on direct human cardiac reprogramming and 2) determine how TBX20 functions as an essential
reprogramming factor during this process. The main objective of this proposal is to identify the critical role of
TBX20 on regeneration of cardiomyocytes during direct cardiac reprogramming. The completion of this
proposal will not only provide mechanistic insight into how cardiomyocyte identity can be regenerated by direct
cardiac reprogramming but also enable us to generate functional-reliable cardiomyocytes directly from human
non-myocytes for potential heart repair.
摘要
从成纤维细胞直接对诱导的心肌细胞(ICM)进行心脏重编程已成为一种
治疗心力衰竭的有希望的治疗策略,心力衰竭仍然是死亡和死亡的主要原因
发达国家的发病率。虽然关于从小鼠细胞产生的ICM已知很多,但
直接心脏重编程适应人类细胞的效率和质量都很低
因为物种之间的内在差异。我们最近报道了单细胞转录分析
在人类心脏重新编程期间,发现ICM的生成不足与
与不发达的基因程序,如离子通道和细胞连接,表明额外的
可能需要重新编程调节心肌细胞功能的因子。在这个研究项目中,我们
一种新的重编程因子TBX20在产生心肌细胞特性中起重要作用的假说
通过建立与心肌细胞功能相关的基因程序。为了支持我们的假设,我们的
初步数据显示,在人类ICM中,TBX20在很大程度上表达不足。虽然强迫表达
在激活基因程序的同时,显著提高了重编程效率
与心肌细胞功能有关。为了检验这一假设,我们建议1)进一步确定影响
TBX20对人类心脏直接重编程的影响和2)确定TBX20如何作为必需的
在这一过程中的重新编程因素。这项建议的主要目标是确定
Tbx20对心脏直接重编程过程中心肌细胞再生的影响。这项工程的完成
该提案不仅提供了对心肌细胞身份如何通过直接
心脏重新编程,也使我们能够直接从人类产生功能可靠的心肌细胞
非心肌细胞用于潜在的心脏修复。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cardiomyocyte Cell-Cycle Regulation in Neonatal Large Mammals: Single Nucleus RNA-Sequencing Data Analysis via an Artificial-Intelligence-Based Pipeline.
- DOI:10.3389/fbioe.2022.914450
- 发表时间:2022
- 期刊:
- 影响因子:5.7
- 作者:Nguyen, Thanh;Wei, Yuhua;Nakada, Yuji;Zhou, Yang;Zhang, Jianyi
- 通讯作者:Zhang, Jianyi
A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming.
- DOI:10.1016/j.xpro.2022.101560
- 发表时间:2022-09-16
- 期刊:
- 影响因子:0
- 作者:Lyra-Leite, Davi M.;Gutierrez-Gutierrez, Oscar;Wang, Meimei;Zhou, Yang;Cyganek, Lukas;Burridge, Paul W.
- 通讯作者:Burridge, Paul W.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yang Zhou其他文献
Yang Zhou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yang Zhou', 18)}}的其他基金
Targeting CHI3L and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
- 批准号:
10850273 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L1 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
- 批准号:
10554375 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L1 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
- 批准号:
10355479 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L1 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
- 批准号:
9887633 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用
- 批准号:
10033650 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用
- 批准号:
10455734 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用
- 批准号:
10245150 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
CHI3L1 及其受体在与肺纤维化相关的血管重塑和肺动脉高压中的作用
- 批准号:
10437834 - 财政年份:2013
- 资助金额:
$ 37.13万 - 项目类别:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
CHI3L1 及其受体在与肺纤维化相关的血管重塑和肺动脉高压中的作用
- 批准号:
10200080 - 财政年份:2013
- 资助金额:
$ 37.13万 - 项目类别:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
CHI3L1 及其受体在与肺纤维化相关的血管重塑和肺动脉高压中的作用
- 批准号:
9573405 - 财政年份:
- 资助金额:
$ 37.13万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Continuing Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Standard Grant
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Fellowship
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Discovery Projects
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Discovery Projects














{{item.name}}会员




